After demonstrating that exposure to obesity-associated systemic factors inhibits SKBR3 cell ERβ expression and modulates ERβ target genes, we next examined whether these effects occur via the regulation of ESR2 transcription or through a post-transcriptional mechanism. The gene discussed is ESR2; the disease is obesity disorder.